Infection Control Today® Editorial Staff

Sepsis often first appears in the emergency department, making diagnosis challenging and leading to delays. This study examines a new, recently FDA-approved test on how to diagnose earlier.

AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.

Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies.

Two investigators from Australia spoke with ICT about how management tools can overcome health care worker reluctance and implement OR safety improvements.

Joshua Rhein, MD, explains why patients who are obese are more likely to develop sepsis.

A recent literature review and meta-analysis sought to determine the effects of COVID-19 lockdown measures on mortality rates. Here's what a team of economists found.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending February 4.

Many people suffer from long COVID, and since COVID-19 is a fairly recent development experts aren’t sure what “long” means exactly. Weeks? Months? Years? A lifetime?

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 28.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 21.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 14.

The vaccine for Omicron looks promising, says Pfizer, but in the meantime, the booster remains the best shot at avoiding infection.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 7.

Just how much celebrating the pandemic-weary public can do turns on the vaccinated or unvaccinated question.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending December 17

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending December 10.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending December 3.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 19.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 12.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending October 29.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending October 22.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending October 15.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending October 1.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending September 24.

Patients with abnormally low blood pressure were less likely to receive antibiotics even though they could benefit from such treatment, according to a recent study.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending September 17.

New antifungal agents that are being investigated for possible use against C. auris, such as Ibrexafungerp (Brexafemme), show promise—so far.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending September 10.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending August 27.

Officials originally said that the boosters would be available 8 months after the last dose, but they’ve changed that to 6. That should help older Americans. But what about children?